Benchmarking biotech and pharmaceutical product development
نویسندگان
چکیده
منابع مشابه
New Product Development in the Pharmaceutical Industry: Evidence from Iran
In today’s competitive world, there are several strategies to deal with the fast changing environment, among which New product development (NPD) is a common strategy. However, almost half of the resources that companies devote to NPD are spent on products that may fail. This issue is particularly highlighted in the pharmaceutical industry mainly because of a long development-time, low success r...
متن کاملNew Product Development in the Pharmaceutical Industry: Evidence from Iran
In today’s competitive world, there are several strategies to deal with the fast changing environment, among which New product development (NPD) is a common strategy. However, almost half of the resources that companies devote to NPD are spent on products that may fail. This issue is particularly highlighted in the pharmaceutical industry mainly because of a long development-time, low success r...
متن کاملEmerging Trends in Biotech/Pharmaceutical Collaborations
This decline can be attributed primarily to a more cautious regulatory climate caused by recent highprofile safety issues. 3 As a result of the heightened bar to obtain FDA approval, the life sciences sector has been plagued by a dearth of new product flow. All players in the industry—even large pharmaceutical companies—have been affected. Notably, only Novartis and GlaxoSmithKline (GSK) releas...
متن کاملInformation Modeling for Pharmaceutical Product Development
Development of a pharmaceutical product involves several inter-related steps with multiple decisions requiring iterative improvements. Large amounts of information, including the properties of a drug substance, interactions of materials, unit operations, equipment etc, have to be gathered and used for decision making. A systematic model of the associated information is thus needed to streamline...
متن کاملBenchmarking B-Cell Epitope Prediction with Quantitative Dose-Response Data on Antipeptide Antibodies: Towards Novel Pharmaceutical Product Development
B-cell epitope prediction can enable novel pharmaceutical product development. However, a mechanistically framed consensus has yet to emerge on benchmarking such prediction, thus presenting an opportunity to establish standards of practice that circumvent epistemic inconsistencies of casting the epitope prediction task as a binary-classification problem. As an alternative to conventional dichot...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Biotechnology
سال: 2014
ISSN: 1087-0156,1546-1696
DOI: 10.1038/nbt.2947